Latest news
Loading news…
Biscayne NeuroTherapeutics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Miami, Florida, United States Founded 2017 1-10 employees For Profit
Biscayne Neurotherapeutics is a clinical-stage biotechnology company which develops novel drugs for central nervous system disorders.
Biscayne NeuroTherapeutics was acquired by Supernus Pharmaceuticals in 2018 for $185M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
4
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 0
- Patents granted
- 4
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
Company Info
- Founded
- 2017
- Employees
- 1-10
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- HQ
- Miami, Florida, United States
- Region
- Greater Miami Area, East Coast, Southern US
- Exit date
- Sep 14, 2018
- Closed
- Sep 13, 2018
Signals & Scores
- Heat score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.6
- Trend (90d)
- 0.3
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Biscayne NeuroTherapeutics
Loading news…
FAQs about Biscayne NeuroTherapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.